JPA Health appoints Ogilvy, Edelman vet as COO
Michael Sloan joined the agency this month as chief operating officer.
News
Vote now for your favorite creative in the MM&M Holiday Contest
Haven’t submitted your entry yet? We’ve extended the deadline until Wednesday, December 11.
Five things for pharma marketers to know: Friday, December 6, 2019
Biogen Alzheimer’s data shows drug benefits; House plans to vote on Nancy Pelosi’s drug price bill; Ebola vaccine stockpile to increase to 500,000 doses.
The Escalator: W2O names two board members
Plus people moves at Ashfield, Area 23 and Envision Pharma Group.
Marketing content comes to telehealth visits
Populus, a health media startup, will coordinate the airing of 15- to 60-second spots prior to and following telehealth consults.
Stigma, isolation and a generation ‘forgotten by society’: pharma marketers’ encounter with sickle-cell patients
While launches for two new sickle-cell treatments get underway, drugmakers find that their disease marketing work has just begun to scratch the surface.
Infographic: What could you buy with the $20.5 trillion Elizabeth Warren’s health plan calls for in new federal spending?
That number got many of us at MM&M thinking: What else can be bought with $20,500,000,000,000?
Five things for pharma marketers to know: Thursday, December 5, 2019
Minnesota sues Juul over teen vaping; J&J says new tests found no asbestos in baby powder; Hospital groups challenge price transparency rule.
Pipeline Report 2020: Drugs rising from R&D purgatory, new vaccines set to surge in coming year
Several candidates relegated to the R&D graveyard re-emerged from their tombs this year and now headline the pharma developmental slate for 2020.
Finn Partners acquires Paris-based Medical & Health Consulting
Medical & Health Consulting represents biopharma, health technology and medical device companies and professional medical associations.
Want to read more?
Please login or register first to view this content.
